Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1987 1
1995 1
2000 1
2002 1
2012 1
2015 1
2017 1
2020 1
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
The treatment of psoriasis with IL-10: rationale and review of the first clinical trials.
Asadullah K, Döcke WD, Sabat RV, Volk HD, Sterry W. Asadullah K, et al. Expert Opin Investig Drugs. 2000 Jan;9(1):95-102. doi: 10.1517/13543784.9.1.95. Expert Opin Investig Drugs. 2000. PMID: 11060663 Review.
Immunosuppressive effects (depressed monocytic HLA-DR expression, TNF-alpha and IL-12 secretion capacity, IL-12 plasma levels and responsiveness to recall antigens) as well as a shift towards a Type 2 cytokine pattern (increasing proportion of I …
Immunosuppressive effects (depressed monocytic HLA-DR expression, TNF-alpha and IL-12 secretion capacity, IL-12 plasma levels …
Dynamic changes of the proportion of HLA-DR and CD38 coexpression subsets on T lymphocytes during IFN-based chronic hepatitis B treatment.
Lin Y, Shen G, Xie S, Bi X, Lu H, Yang L, Jiang T, Deng W, Wang S, Zhang L, Lu Y, Gao Y, Hao H, Wu S, Liu R, Chang M, Xu M, Hu L, Chen X, Huang R, Li M, Xie Y. Lin Y, et al. Front Immunol. 2023 Jan 24;13:1116160. doi: 10.3389/fimmu.2022.1116160. eCollection 2022. Front Immunol. 2023. PMID: 36761161 Free PMC article.
BACKGROUND: To investigate the changes of human leukocyte antigen DR (HLA-DR) and CD38 coexpression subsets on T lymphocytes following interferon (IFN) therapy for those who have chronic hepatitis B (CHB). ...CONCLUSIONS: The spectrum of …
BACKGROUND: To investigate the changes of human leukocyte antigen DR (HLA-DR) and CD38 coexpression subsets on T …
Comprehensive analysis of the immune pattern of T cell subsets in chronic myeloid leukemia before and after TKI treatment.
Yao D, Lai J, Lu Y, Zhong J, Zha X, Huang X, Liu L, Zeng X, Chen S, Weng J, Du X, Li Y, Xu L. Yao D, et al. Front Immunol. 2023 Jan 19;14:1078118. doi: 10.3389/fimmu.2023.1078118. eCollection 2023. Front Immunol. 2023. PMID: 36742315 Free PMC article.
RESULTS: CD38 or HLA-DR positive PB CD8+TN and TCM cells decreased in the DN-CML patients and this was further decreased in TKI-F patients. Meanwhile, the level of PD-1 elevated in CD8+ TEM and TEMRA cells from PB in all groups. Among BM sample, the level of HLA …
RESULTS: CD38 or HLA-DR positive PB CD8+TN and TCM cells decreased in the DN-CML patients and this was further decreased in TK …
Methylprednisolone treatment increases the proportion of the highly suppressive HLA-DR(+)-Treg-cells in transplanted patients.
Seissler N, Schmitt E, Hug F, Sommerer C, Zeier M, Schaier M, Steinborn A. Seissler N, et al. Transpl Immunol. 2012 Dec;27(4):157-61. doi: 10.1016/j.trim.2012.09.003. Epub 2012 Sep 26. Transpl Immunol. 2012. PMID: 23022208
Recently, we showed that the suppressive activity of a Treg cell population depends decisively on their percentage of highly suppressive HLA-DR(high+)-Treg cells, which are strongly reduced in rejecting transplant patients. ...In patients treated with steroid bolus …
Recently, we showed that the suppressive activity of a Treg cell population depends decisively on their percentage of highly suppressive …
Monitoring Anti-tuberculosis Treatment Response Using Analysis of Whole Blood Mycobacterium tuberculosis Specific T Cell Activation and Functional Markers.
Vickers MA, Darboe F, Muefong CN, Mbayo G, Barry A, Gindeh A, Njie S, Riley AJ, Sarr B, Sambou B, Dockrell HM, Charalambous S, Rachow A, Owolabi O, Jayasooriya S, Sutherland JS. Vickers MA, et al. Front Immunol. 2020 Sep 9;11:572620. doi: 10.3389/fimmu.2020.572620. eCollection 2020. Front Immunol. 2020. PMID: 33679684 Free PMC article.
RESULTS: There was a significant increase in the proportion of CD4(+)CD27(+) cells expressing CD38 and HLA-DR following EC stimulation at 2 months compared to baseline (p = 0.0328 and p = 0.0400, respectively). Following PPD stimulation, slow treatment …
RESULTS: There was a significant increase in the proportion of CD4(+)CD27(+) cells expressing CD38 and HLA-DR fo …
Immune Cell Subsets Evaluation as a Predictive Tool for Hepatitis B Infection Outcome and Treatment Responsiveness.
Kandilarova SM, Georgieva AI, Mihaylova AP, Baleva MP, Atanasova VK, Petrova DV, Popov GT, Naumova EJ. Kandilarova SM, et al. Folia Med (Plovdiv). 2017 Mar 1;59(1):53-62. doi: 10.1515/folmed-2017-0008. Folia Med (Plovdiv). 2017. PMID: 28384114
Fifty-six patients were treatment-naive, 20 were treated with interferons and 42 with nucleoside/ nucleotide analogues. RESULTS: Deficiency of T lymphocytes, helper-inducer (CD3+CD4+), suppressorcytotoxic (CD8+CD3+) and cytotoxic (CD8+CD11b-, CD8+CD28+) subsets, act …
Fifty-six patients were treatment-naive, 20 were treated with interferons and 42 with nucleoside/ nucleotide analogues. RESULTS: Deficiency …
Epidermal T lymphocytes and dendritic cells in chronic plaque psoriasis: the effects of PUVA treatment.
Baker BS, Swain AF, Griffiths CE, Leonard JN, Fry L, Valdimarsson H. Baker BS, et al. Clin Exp Immunol. 1985 Sep;61(3):526-34. Clin Exp Immunol. 1985. PMID: 3878241 Free PMC article.
The numbers and HLA-DR expression of T cell subsets and dendritic cells in chronic psoriatic plaques were compared to previously reported findings in spontaneously resolving guttate lesions, and the effects of PUVA treatment on these cell populations studied. ...Den …
The numbers and HLA-DR expression of T cell subsets and dendritic cells in chronic psoriatic plaques were compared to previous …
T and B lymphocyte subsets in patients with unexplained recurrent spontaneous abortion: IVIG versus placebo treatment.
Jablonowska B, Palfi M, Matthiesen L, Selbing A, Kjellberg S, Ernerudh J. Jablonowska B, et al. Am J Reprod Immunol. 2002 Nov;48(5):312-8. doi: 10.1034/j.1600-0897.2002.01010.x. Am J Reprod Immunol. 2002. PMID: 12516653
Circulating lymphocyte subsets with focus on T-cell subpopulations were determined by flow cytometry. RESULTS: The proportions of human leukocyte antigen (HLA)-DR positive T cells (CD3+ HLA-DR+), T-killer/effector cells (CD8+ S6F1+ …
Circulating lymphocyte subsets with focus on T-cell subpopulations were determined by flow cytometry. RESULTS: The proportions of hum …
T lymphocytes in ankylosing spondylitis and the influence of sulphasalazine treatment.
Feltelius N, Hällgren R, Sjöberg O. Feltelius N, et al. Clin Rheumatol. 1987 Dec;6(4):545-52. doi: 10.1007/BF02330592. Clin Rheumatol. 1987. PMID: 2896558
Twenty-nine patients with ankylosing spondylitis (AS) were studied in an attempt to evaluate the role of T lymphocytes in this disease and a possible influence of treatment. ...Leu-7+ cells appeared in increased proportions. An increased prop …
Twenty-nine patients with ankylosing spondylitis (AS) were studied in an attempt to evaluate the role of T lymphocytes in this …
Peripheral blood CD4(+)CD25(+)CD127(low) regulatory T cells are significantly increased by tocilizumab treatment in patients with rheumatoid arthritis: increase in regulatory T cells correlates with clinical response.
Kikuchi J, Hashizume M, Kaneko Y, Yoshimoto K, Nishina N, Takeuchi T. Kikuchi J, et al. Arthritis Res Ther. 2015 Jan 21;17(1):10. doi: 10.1186/s13075-015-0526-4. Arthritis Res Ther. 2015. PMID: 25604867 Free PMC article.
RESULTS: Clinical Disease Activity Index (CDAI) remission was achieved in 53.8% of patients at week 52 of TCZ therapy. The proportions of CD4(+)CD25(+)CD127(low) regulatory T cells (Treg) and HLA-DR(+) activated Treg cells significantly …
RESULTS: Clinical Disease Activity Index (CDAI) remission was achieved in 53.8% of patients at week 52 of TCZ therapy. The proport …
11 results